for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Journal of Clinical Urology
   Journal TOC RSS feeds Export to Zotero [9 followers]  Follow    
   Hybrid Journal Hybrid journal (It can contain Open Access articles)
     ISSN (Print) 2051-4158 - ISSN (Online) 2051-4166
     Published by Sage Publications Homepage  [742 journals]
  • Editorial
    • Authors: Pearce; I.
      Pages: 307 - 307
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814550444|hwp:resource-id:spuro;7/5/307
      Issue No: Vol. 7, No. 5 (2014)
       
  • Cryotherapy in prostate cancer
    • Authors: Phillips, J. M; Catarinicchia, S, Krughoff, K, Barqawi, A. B.
      Pages: 308 - 317
      Abstract: Review objectives: Cryotherapy use has increased due to technological advances. A review of the literature was performed to evaluate the efficacy and outcomes of whole gland, salvage and targeted focal cryotherapy in the management of prostate cancer. Review findings: Cryotherapy use has increased significantly over the last 10 years with a trend towards focal ablation. Whole gland cryotherapy, salvage cryotherapy and focal cryotherapy biochemical recurrence rates appear to be comparable to other treatment modalities for low risk disease, however biochemical failure remains difficult to compare across studies due to a lack of consensus regarding appropriate end points for evaluation of cryotherapy. Short-term focal cryotherapy outcomes are encouraging. Side effect profiles for cryotherapy have significantly improved with fourth generation systems while salvage cryotherapy continues to carry a slightly higher risk of incontinence than primary whole gland cryotherapy. The incidence of erectile dysfunction after focal cryotherapy is dramatically lower than that for whole gland ablation. Conclusions: Cryotherapy continues to have an active role in the primary and salvage treatment of prostate cancer. Targeted focal cryotherapy is a promising treatment with minimal morbidity. Further long-term data is needed to support targeted therapy in addition to direct comparison with other treatment modalities.
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814521806|hwp:master-id:spuro;2051415814521806
      Issue No: Vol. 7, No. 5 (2014)
       
  • Caesarean bladder and ureteric injuries in the UK
    • Authors: Rashid, T. G; Revicky, V, Terry, T. R.
      Pages: 318 - 322
      Abstract: Lower segment caesarean section (LSCS)-related lower urinary tract injuries are rare. The incidence is rising because of the increasing number of LCSCs being performed. In this review, we classify such injuries into three types and outline their management.
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814533108|hwp:master-id:spuro;2051415814533108
      Issue No: Vol. 7, No. 5 (2014)
       
  • The cost of photoselective vaporization of the prostate compared to
           transurethral resection of the prostate: Experience in a large public
           Australian teaching centre
    • Authors: McCahy, P; Cheng, K, Paul, E, Gleeson, J.
      Pages: 323 - 337
      Abstract: Objective: The purpose of this study was to compare the cost of photoselective vaporization of the prostate (PVP) with transurethral resection of the prostate (TURP) in the treatment of men with bladder outflow obstruction (BOO). Patients and methods: Men underwent PVP or TURP for clinical BOO or urinary retention. We developed a cost framework to calculate the costs of theatre, recovery and ward time in our publically funded institution and calculated a cost for each procedure including the initial stay and any associated admissions over the first 60 days. These costs were statistically analyzed. Results: A total of 99 men underwent PVP and 97 had TURP. Groups were well matched for age and operative indication. The American Society of Anesthesia (ASA) grade was higher for the PVP group with more taking anticoagulants (36% versus 3.1%). PVP was 74% more expensive (median AUD$4243 vs AUD$2439, p
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814526391|hwp:master-id:spuro;2051415814526391
      Issue No: Vol. 7, No. 5 (2014)
       
  • The clinic-pathological characteristics of prostate cancer in an Irish
           subpopulation with a serum PSA less than 4.0ng/ml
    • Authors: O'Kelly, F; McGuire, B, Flynn, R, Grainger, R, McDermott, T, Thornhill, J.
      Pages: 338 - 343
      Abstract: Background: Prostate specific antigen (PSA) has been used as a biomarker for prostate cancer for the last 20 years. Traditionally, a serum PSA
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814530290|hwp:master-id:spuro;2051415814530290
      Issue No: Vol. 7, No. 5 (2014)
       
  • Single surgeon experience of augmentation ileocystoplasty in the
           management of refractory idiopathic detrusor overactivity
    • Authors: Pisipati, S; Khan, F, Kinder, R. B.
      Pages: 344 - 350
      Abstract: Background: Until a decade ago, augmentation ileocystoplasty (AIC) was the only major advancement over anti-muscarinics for intractable idiopathic detrusor overactivity (IDO). Clam ileocystoplasty has been proposed to restore continence and preserve urethral voiding. While intravesical botulinum and neuromodulation have revolutionised the treatment of this condition, arguably there remains a place for bladder augmentation in the surgical armamentarium. Objective: This study presents a single surgeon experience of clam ileocystoplasty performed for intractable IDO at our institution. Methods: A retrospective case-note review was performed over a 9-year period. Data on basic patient demographics, urodynamic findings, pre-operative treatments administered, post-operative complications and response to surgery were documented. Results: In total, 22 patients were identified with a median age of 42.4 years. The predominant symptoms were urgency (100%) and urge incontinence (96%). All our patients were incontinent pre-operatively with 59% using pads. Ambulatory cystometry was helpful in 27% patients in whom standard +/- video studies were inconclusive. Of the cohort, 100%, 82% and 55% had one, two and three anticholinergics, respectively. Only 18% received intravesical botulinum toxin A pre-operatively. Some 77% were cured of their storage symptoms and incontinence; 18% had residual incontinence. Of these, genuine urodynamic stress incontinence was demonstrated in 9% and improved with tension-free vaginal tape. Some 9% had Clavien 3b complications requiring laparotomy. Mortality was nil. Conclusion: In young patients with refractory IDO, clam ileocystoplasty serves as a permanent, effective technique for symptom reduction and restoration of continent urethral voiding with few complications.
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814530920|hwp:master-id:spuro;2051415814530920
      Issue No: Vol. 7, No. 5 (2014)
       
  • An assessment on the quality of abstracts presented at the British
           Association of Urological Surgeons annual meeting
    • Authors: Jones, J; Lam, J, Stewart, G, McNeill, S, Laird, A.
      Pages: 351 - 356
      Abstract: Objectives: To assess the quality of abstracts presented at the British Association of Urological Surgeons (BAUS) annual meeting using standardized reporting guidelines and examine whether abstract quality is associated with conversion to full-text publication. Materials and methods: Two standardized assessment forms based on CONSORT/STROBE guidelines were used to score abstracts from the 2009 BAUS meeting retrospectively. A high score ratio was defined as >50% of criteria. Kaplan–Meier analysis examined effect of score ratio on time to publication; logistic regression examined predictive potential of variables including; session topic, study design, country of origin and number of institutions to high score ratio and the effects the above factors and a high score ratio on the likelihood of full-text publication. Results: In total, 127 abstracts were included. The mean score ratio was 63.6% (SD 13.3%) for observational studies and 62.7% (SD 9.5%) for randomized controlled trials (RCTs). Nine RCT abstracts and 91 non-RCT abstracts achieved a high score ratio. topic, study design, country of origin and number of institutions did not predict a high score ratio or subsequent full-length publication using multivariate logistic regression. Full-length publication was achieved for 43 (33.9%) abstracts. Mean time to publication was 17.2 months. quality did not predict time to publication (p=0.706). Conclusion: BAUS abstracts are of high quality, and compare favourably with other urological meetings. While abstract quality does not independently predict full-length publication, most abstracts do not progress to full-length publication and thus we advocate the use of standardized reporting guidelines to ensure accurate interpretation of study methodology and results.
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814531258|hwp:master-id:spuro;2051415814531258
      Issue No: Vol. 7, No. 5 (2014)
       
  • Gluteal-fold adipofascial perforator flap transposition for rectourethral
           fistula reconstruction
    • Authors: Fujioka, M; Hayashida, K, Norooka, S, Saijo, H, Kuwabara, K, Nonaka, T, Hayashi, M.
      Pages: 357 - 360
      Abstract: If a rectourinary fistula does not close spontaneously, it requires surgical closure. We present our experience of rectourethral fistula reconstruction using a gluteal-fold perforator flap, resulting in a successful outcome. The patient was a 64-year-old man with prostate cancer who underwent radical prostatectomy. However, he developed rectourinary fistula, which required surgical closure. A dissection was undertaken to divide the fistula tract, and the rectal and urethral defect were closed. A 12.0x3.0 cm gluteal-fold adipofascial perforator flap was harvested and placed in the space between the rectum and urethra. The viability of lap was favourable, without infection or necrosis. The patient could walk the next day, and was discharged 2 weeks later without fecaluria or liquid stool. We conclude that the gluteal-fold adipofascial perforator flap offers excellent functional advantages in rectourethral fistula reconstruction with minimal morbidity at the donor site.
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814527446|hwp:master-id:spuro;2051415814527446
      Issue No: Vol. 7, No. 5 (2014)
       
  • Seminal vesicle phyllodes tumour treated by transperitoneal laparoscopic
           resection
    • Authors: Tudor, E. C; Cutress, M. L, McNeill, S. A.
      Pages: 361 - 363
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415813507255|hwp:master-id:spuro;2051415813507255
      Issue No: Vol. 7, No. 5 (2014)
       
  • Intravesical gentamicin treatment of recurrent Escherichia coli urinary
           tract infections in a patient with multiple antibiotic allergies
    • Authors: Naderi, K; Urwin, G, Casey, R.
      Pages: 364 - 366
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415813508545|hwp:master-id:spuro;2051415813508545
      Issue No: Vol. 7, No. 5 (2014)
       
  • 'Is the printed journal dead''
    • Authors: Hadjipavlou, M; Sriprasad, S, Rane, A.
      Pages: 367 - 368
      PubDate: 2014-09-01T01:53:52-07:00
      DOI: 10.1177/2051415814542122|hwp:master-id:spuro;2051415814542122
      Issue No: Vol. 7, No. 5 (2014)
       
  • Bone mineral density screening in patients with prostate cancer on
           androgen-deprivation therapy: Data from a single center
    • Authors: Hariman, A; Bufalino, D, Hess, B, Obi, C, Price, R, Zelisko, S, Emanuele, N, Mazhari, A.
      Pages: 369 - 370
      PubDate: 2014-09-01T01:53:53-07:00
      DOI: 10.1177/2051415814545702|hwp:master-id:spuro;2051415814545702
      Issue No: Vol. 7, No. 5 (2014)
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014